title: [Prenatal screening for Trypanosoma cruzi and human T lymphotropic virus types 1 and 2 in pregnant Latin American women].
abstract: BACKGROUND
  To estimate the seroprevalence of infection by Trypanosoma cruzi and human T lymphotropic virus (HTLV) in pregnant Latin American women.
  
  
  METHODS
  Serological survey carried out in pregnant Latin American women attending the antenatal care clinic of a Spanish hospital from January 2006 to June 2007.
  
  
  RESULTS
  Of the 229 women enrolled, 4 had antibodies against T. cruzi (1.75%; 95% confidence interval [95% CI], 0.68-4.4); 2 of these women came from Bolivia (13.33%; 95% CI, 3.73-37.88) and the other 2 from Paraguay (11.76%; 95% CI, 3.29-34.33). None of the women had anti-HTLV-1 antibodies (95% CI, 0-1.6), and 2 had HTLV-2 antibodies (0.87; 95% CI, 0.24-3.12).
  
  
  CONCLUSIONS
  A notable percentage of pregnant immigrant women from Latin American had T. cruzi infection. The seroprevalence of HTLV infection is low.
authors.affiliation: Unidad de Enfermedades Infecciosas, Servicio de Medicina Interna, Hospital General Universitario de Elche, Alicante, España. jramosrincon@yahoo.es
authors.forename: José Manuel
authors.initials: JM
authors.lastname: Ramos
authors.forename: Alfredo
authors.initials: A
authors.lastname: Milla
authors.forename: Victoria
authors.initials: V
authors.lastname: Sánchez
authors.forename: Mireia
authors.initials: M
authors.lastname: Vergés
authors.forename: Carlos
authors.initials: C
authors.lastname: Toro
authors.forename: Félix
authors.initials: F
authors.lastname: Gutiérrez
mesh_terms: D000328:Adult; D000818:Animals; D000913:Antibodies, Protozoan / Q000097:blood; D014355:Chagas Disease / Q000175:diagnosis / Q000453:epidemiology* / Q000517:prevention & control / Q000635:transmission; D054242:Emigrants and Immigrants / Q000706:statistics & numerical data*; D005260:Female; D015481:HTLV-I Antibodies / Q000097:blood; D015490:HTLV-I Infections / Q000175:diagnosis / Q000453:epidemiology* / Q000517:prevention & control / Q000635:transmission; D015482:HTLV-II Antibodies / Q000097:blood; D015491:HTLV-II Infections / Q000175:diagnosis / Q000453:epidemiology* / Q000517:prevention & control / Q000635:transmission; D006785:Hospitals, University / Q000706:statistics & numerical data; D015368:Human T-lymphotropic virus 1 / Q000276:immunology; D015367:Human T-lymphotropic virus 2 / Q000276:immunology; D006801:Humans; D007231:Infant, Newborn; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control*; D007843:Latin America / Q000208:ethnology; D008403:Mass Screening; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000175:diagnosis / Q000453:epidemiology*; D011295:Prenatal Care; D016036:Seroepidemiologic Studies; D013030:Spain / Q000453:epidemiology; D014349:Trypanosoma cruzi / Q000276:immunology; D055815:Young Adult
chemical_list: D000913:Antibodies, Protozoan; D015481:HTLV-I Antibodies; D015482:HTLV-II Antibodies